<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="letter">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Diabetes Care</journal-id>
      <journal-id journal-id-type="iso-abbrev">Diabetes Care</journal-id>
      <journal-id journal-id-type="hwp">diacare</journal-id>
      <journal-id journal-id-type="pmc">dcare</journal-id>
      <journal-id journal-id-type="publisher-id">Diabetes Care</journal-id>
      <journal-title-group>
        <journal-title>Diabetes Care</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0149-5992</issn>
      <issn pub-type="epub">1935-5548</issn>
      <publisher>
        <publisher-name>American Diabetes Association</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">25715421</article-id>
      <article-id pub-id-type="pmc">4876698</article-id>
      <article-id pub-id-type="publisher-id">2124</article-id>
      <article-id pub-id-type="doi">10.2337/dc14-2124</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>e-Letters: Observations</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Remission of Severe Neonatal Diabetes With Very Early Sulfonylurea Treatment</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-2370-4479</contrib-id>
          <name>
            <surname>Marshall</surname>
            <given-names>Bess A.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
          <xref ref-type="corresp" rid="cor1"/>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-6998-0364</contrib-id>
          <name>
            <surname>Green</surname>
            <given-names>Rebecca P.</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">
            <sup>3</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wambach</surname>
            <given-names>Jennifer</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>White</surname>
            <given-names>Neil H.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Remedi</surname>
            <given-names>Maria S.</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-4929-2134</contrib-id>
          <name>
            <surname>Nichols</surname>
            <given-names>Colin G.</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
        </contrib>
        <aff id="aff1"><sup>1</sup>Department of Pediatrics, Washington University School of Medicine, St. Louis, MO</aff>
        <aff id="aff2"><sup>2</sup>Department of Cell Biology, Washington University School of Medicine, St. Louis, MO</aff>
        <aff id="aff3"><sup>3</sup>Springfield Clinic, Springfield, IL</aff>
      </contrib-group>
      <author-notes>
        <corresp id="cor1">Corresponding author: Bess A. Marshall, <email>marshall@kids.wustl.edu</email>.</corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>3</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>12</day>
        <month>2</month>
        <year>2015</year>
      </pub-date>
      <volume>38</volume>
      <issue>3</issue>
      <fpage>e38</fpage>
      <lpage>e39</lpage>
      <permissions>
        <copyright-statement>&#xA9; 2015 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered.</copyright-statement>
        <copyright-year>2015</copyright-year>
      </permissions>
      <self-uri xlink:title="pdf" xlink:href="dc142124.pdf"/>
      <counts>
        <page-count count="2"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro" id="s1">
      <title>Introduction</title>
      <p content-type="flushleft">Mutations in <italic>KCNJ11</italic> and <italic>ABCC8</italic> can cause neonatal diabetes mellitus (NDM) (<xref rid="B1" ref-type="bibr">1</xref>) that may respond to sulfonylureas (<xref rid="B2" ref-type="bibr">2</xref>).</p>
      <p>We report three NDM infants treated with glyburide very early in life who were able to maintain good glycemic control with minimal dosing.</p>
    </sec>
    <sec id="s2">
      <title>Case 1</title>
      <p content-type="flushleft">This 6-year-old male (Case-1-male) was previously reported at birth (<xref rid="B3" ref-type="bibr">3</xref>). Mother and sister (Case-1-female) both had NDM and were given insulin for 24 and 6 years, respectively, then treated with high-dose glyburide; mother still requires some insulin. Case-1-male had NDM at 3 days and was given glyburide 0.2 mg/kg/day, weaned to 0.05 mg/kg/day, and maintained normal hemoglobin A<sub>1c</sub> for 5 years (<xref ref-type="fig" rid="F1">Fig. 1<italic>A</italic></xref>) continuing glyburide 0.075 mg thrice daily (mixing a crushed 5 mg tablet with 10 cc water, giving 0.15 cc for each dose, 0.012 mg/kg/day). All had a heterozygous mutation in <italic>KCNJ11</italic> (R201H).</p>
      <fig id="F1" fig-type="figure" orientation="portrait" position="float">
        <label>Figure 1</label>
        <caption>
          <p><italic>A</italic>: Hemoglobin A<sub>1c</sub> (% and mmol/mol) in Case-1-male (squares) and Case-1-female (triangles) and glyburide dose (mg/kg/12 h) of Case-1-male (circles) during the months of age indicated. The asterisk and cross mark the age at which glyburide was initiated in Case-1-male and Case-1-female, respectively. <italic>B</italic>: Dose of glyburide (mg/kg/12 h) and plasma glucose (mmol/L) in the first 11 days of life in Case 2. The highest plasma glucose concentration of each day is shown by the circles, the lowest by the triangles. <italic>C</italic>: Glyburide dose (mg/kg/12 h), intravenous insulin infusion rate (U/kg/h), intravenous glucose infusion rate (mg/kg/min), and plasma glucose (mmol/L) in the first 130 days of life of Case 3 (circles are highest plasma glucose concentration per day, triangles are lowest).</p>
        </caption>
        <graphic xlink:href="dc142124f1"/>
      </fig>
    </sec>
    <sec id="s3">
      <title>Case 2</title>
      <p content-type="flushleft">A boy with hyperglycemia (125&#x2013;247 mg/dL) (6.9&#x2013;13.7 mmol/L) at 3 days old was given glyburide 0.2 mg/kg twice daily on day 6 and weaned to 0.05 mg/kg/day by day 10 (<xref ref-type="fig" rid="F1">Fig. 1<italic>B</italic></xref>). Mother and maternal uncle and aunt, diagnosed with diabetes at age 15, 10, and 8 years, respectively, take insulin. The infant and mother had heterozygous mutation in <italic>ABCC8</italic> (c1463C&gt;T [p.Thr488Ile]); these results were not available until day of life 37. Mother has been weaned off insulin to glyburide 2.5 mg thrice daily.</p>
    </sec>
    <sec id="s4">
      <title>Case 3</title>
      <p content-type="flushleft">A girl, 27 weeks' gestation, with hyperglycemia at 3 days old (<xref ref-type="fig" rid="F1">Fig. 1<italic>C</italic></xref>), was started on an insulin infusion. On day 20, she was given glyburide 0.1 mg/kg twice daily, later reduced to 0.04 mg/kg twice daily, and insulin was discontinued. At 1 month, glyburide was stopped for necrotizing enterocolitis. Good glycemic control continued without glyburide or insulin: hemoglobin A<sub>1c</sub> was 4.6% (27 mmol/mol) after 1 year. Genetic testing obtained later identified the same <italic>ABCC8</italic> mutation as in the unrelated Case 2. Parents have no history of diabetes.</p>
    </sec>
    <sec sec-type="conclusions" id="s5">
      <title>Conclusions</title>
      <p content-type="flushleft">These outcomes suggest that functional &#x3B2;-cells may be preserved with low doses of sulfonylurea started very early in life without insulin administration or risk of severe hypoglycemia. This is consistent with murine data indicating that early treatment with sulfonylureas preserves &#x3B2;-cells in K<sub>ATP</sub>-dependent diabetes (<xref rid="B4" ref-type="bibr">4</xref>).</p>
      <p>These low doses of glyburide are consistent with an infant reported with hyperglycemia at 2 days, placed on glyburide on day 7, and successfully treated using 0.02 mg/kg/day (<xref rid="B5" ref-type="bibr">5</xref>). In these cases, genetic testing was delayed due to birth in a country without quick access to testing, refusal of insurance coverage, or extreme prematurity. Khurana et al. (<xref rid="B5" ref-type="bibr">5</xref>) suggested that &#x201C;patients with the onset of diabetes prior to 1 year of age who have a strong family history of early-onset diabetes&#x201D; receive a trial of sulfonylurea even without genetic testing.</p>
      <p>We extend this recommendation to suggest that a trial of sulfonylurea be immediately given in all cases of diabetes diagnosed in the first weeks of life. Very early sulfonylurea treatment may prevent progression to severe NDM and preserve sufficient glucose-modulated insulin secretion to render the diabetes mild and reduce acute and long-term complications.</p>
    </sec>
  </body>
  <back>
    <ack>
      <title>Article Information</title>
      <p><bold>Duality of Interest.</bold> No potential conflicts of interest relevant to this article were reported.</p>
      <p><bold>Author Contributions.</bold> B.A.M. wrote the manuscript and contributed patient data. R.P.G., J.W., and N.H.W. contributed patient data and reviewed the manuscript. M.S.R. and C.G.N. provided scientific interpretation and reviewed the manuscript. B.A.M. is the guarantor of this work and, as such, had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.</p>
    </ack>
    <ref-list>
      <title>References</title>
      <ref id="B1">
        <label>1</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gloyn</surname><given-names>AL</given-names></name>, <name><surname>Cummings</surname><given-names>EA</given-names></name>, <name><surname>Edghill</surname><given-names>EL</given-names></name>, <etal/></person-group>
<article-title>Permanent neonatal diabetes due to paternal germline mosaicism for an activating mutation of the KCNJ11 gene encoding the Kir6.2 subunit of the beta-cell potassium adenosine triphosphate channel</article-title>. <source>J Clin Endocrinol Metab</source>
<year>2004</year>;<volume>89</volume>:<fpage>3932</fpage>&#x2013;<lpage>3935</lpage><pub-id pub-id-type="pmid">15292329</pub-id></mixed-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karges</surname><given-names>B</given-names></name>, <name><surname>Meissner</surname><given-names>T</given-names></name>, <name><surname>Icks</surname><given-names>A</given-names></name>, <name><surname>Kapellen</surname><given-names>T</given-names></name>, <name><surname>Holl</surname><given-names>RW</given-names></name></person-group>
<article-title>Management of diabetes mellitus in infants</article-title>. <source>Nat Rev Endocrinol</source>
<year>2012</year>;<volume>8</volume>:<fpage>201</fpage>&#x2013;<lpage>211</lpage><pub-id pub-id-type="pmid">22124439</pub-id></mixed-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wambach</surname><given-names>JA</given-names></name>, <name><surname>Marshall</surname><given-names>BA</given-names></name>, <name><surname>Koster</surname><given-names>JC</given-names></name>, <name><surname>White</surname><given-names>NH</given-names></name>, <name><surname>Nichols</surname><given-names>CG</given-names></name></person-group>
<article-title>Successful sulfonylurea treatment of an insulin-na&#xEF;ve neonate with diabetes mellitus due to a KCNJ11 mutation</article-title>. <source>Pediatr Diabetes</source>
<year>2010</year>;<volume>11</volume>:<fpage>286</fpage>&#x2013;<lpage>288</lpage><pub-id pub-id-type="pmid">19656320</pub-id></mixed-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Remedi</surname><given-names>MS</given-names></name>, <name><surname>Agapova</surname><given-names>SE</given-names></name>, <name><surname>Vyas</surname><given-names>AK</given-names></name>, <name><surname>Hruz</surname><given-names>PW</given-names></name>, <name><surname>Nichols</surname><given-names>CG</given-names></name></person-group>
<article-title>Acute sulfonylurea therapy at disease onset can cause permanent remission of KATP-induced diabetes</article-title>. <source>Diabetes</source>
<year>2011</year>;<volume>60</volume>:<fpage>2515</fpage>&#x2013;<lpage>2522</lpage><pub-id pub-id-type="pmid">21813803</pub-id></mixed-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khurana</surname><given-names>D</given-names></name>, <name><surname>Contreras</surname><given-names>M</given-names></name>, <name><surname>Malhotra</surname><given-names>N</given-names></name>, <name><surname>Bargman</surname><given-names>R</given-names></name></person-group>
<article-title>The diagnosis of neonatal diabetes in a mother at 25 years of age</article-title>. <source>Diabetes Care</source>
<year>2012</year>;<volume>35</volume>:<fpage>e59</fpage><pub-id pub-id-type="pmid">22826452</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
